Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

PARK7/DJ1 antibody (C-Term)

The Rabbit Polyclonal anti-PARK7/DJ1 antibody has been validated for WB, IHC and ELISA. It is suitable to detect PARK7/DJ1 in samples from Human.
Rockland
Catalog No. ABIN129620
Supplier Product No.: 600-401-691

Quick Overview for PARK7/DJ1 antibody (C-Term) (ABIN129620)

Target

See all PARK7/DJ1 (PARK7) Antibodies
PARK7/DJ1 (PARK7) (Parkinson Protein 7 (PARK7))

Reactivity

  • 110
  • 77
  • 58
  • 7
  • 5
  • 4
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Human

Host

  • 113
  • 23
  • 2
  • 1
Rabbit

Clonality

  • 108
  • 31
Polyclonal

Conjugate

  • 84
  • 14
  • 12
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This PARK7/DJ1 antibody is un-conjugated

Application

  • 114
  • 67
  • 44
  • 34
  • 31
  • 27
  • 23
  • 14
  • 13
  • 13
  • 5
  • 5
  • 5
  • 4
  • 2
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC), ELISA
  • Binding Specificity

    • 29
    • 16
    • 11
    • 11
    • 9
    • 4
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    C-Term

    Supplier Product No.

    600-401-691

    Supplier

    Rockland

    Purpose

    PARK-7 Antibody

    Cross-Reactivity (Details)

    Reactivity occurs against human PARK7 protein.

    Characteristics

    Synonyms: rabbit anti-PARK7 antibody, PARK-7, PARK 7, Protein DJ-1, Parkinson disease protein 7, Parkinsonism-associated deglycase, DJ-1 mutant, oncogene DJ1, DJ-1 oncogene product

    Purification

    This is an affinity purified antibody produced by immunoaffinity chromatography using the immunizing peptide after immobilization to a solid phase.

    Sterility

    Sterile filtered

    Immunogen

    Immunogen: This affinity purified antibody was prepared from whole rabbit serum produced by repeated immunizations with a synthetic peptide corresponding to the C-terminus of Human PARK7 protein.

    Immunogen Type: Conjugated Peptide

    Isotype

    IgG
  • Application Notes

    Immunohistochemistry Dilution: 2 mg/mL - 5 μg/mL

    Application Note: This affinity purified antibody has been tested for use in ELISA, immunohistochemistry and western blot.  Specific conditions for reactivity should be optimized by the end user. Expect a band approximately 28 kDa in size corresponding to PARK7 by western blotting in the appropriate cell lysate or extract.

    Western Blot Dilution: 1:500 - 1:2,000

    ELISA Dilution: 1:10,000 - 1:50,000

    Other: User Optimized

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    1.3 mg/mL

    Buffer

    Buffer: 0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2

    Stabilizer: None

    Preservative: 0.01 % (w/v) Sodium Azide

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C,-20 °C

    Storage Comment

    Store vial at -20° C prior to opening. Aliquot contents and freeze at -20° C or below for extended storage. Avoid cycles of freezing and thawing. Centrifuge product if not completely clear after standing at room temperature. This product is stable for several weeks at 4° C as an undiluted liquid. Dilute only prior to immediate use.

    Expiry Date

    12 months
  • Target

    PARK7/DJ1 (PARK7) (Parkinson Protein 7 (PARK7))

    Alternative Name

    PARK7

    Background

    Background: The product of the PARK7 gene, known as PARK7, Parkinson disease (autosomal recessive, early onset) 7, DJ-1 mutant, and DJ-1 oncogene product, functions as a positive regulator of androgen receptor-dependent transcription.  PARK7 may also function as a redox-sensitive chaperone and as a sensor for oxidative stress and also has been reported to prevent aggregation of SNCA.   PARK7 protects neurons against oxidative stress and cell death and plays a role in fertilization. While PARK7 has no proteolytic activity, it does have a weak transforming activity.  PARK7 forms a homodimer and binds to DJBP and PIAS2.  PARK7 is part of a ternary complex containing PARK7, DJBP and AR and shows both a nuclear and cytoplasmic localization.  Diseases include Early onset autosomal recessive Parkinson Disease 7 and Parkinson Disease Juvenile Type 2.

    Gene ID

    11315, 31543380

    UniProt

    Q99497

    Pathways

    Intracellular Steroid Hormone Receptor Signaling Pathway, Regulation of Intracellular Steroid Hormone Receptor Signaling, Proton Transport
You are here:
Chat with us!